The article you are looking for is not available.
Perhaps you would be interested in our most recent articles.
Isolation technology has significantly improved our ability to manufacture sterile drug products aseptically. Its performance far exceeds that of other aseptic technologies and has been successfully ...
read more
Many early adopters of rapid methods later went back to traditional methods. What were these technologies and when did early adopters continue using them?
read more
When properly integrated through appropriate design planning, validation and alignment with regulatory expectations, continuous monitoring can strengthen contamination control strategies and support ...
read more
GLP-1s have generated large amounts of new safety work. Pharmacovigilance systems are struggling to cope with the volume and complexity.
read more
Chromatography has an important role, but relying on it too long may cost of goods, extend timelines, and complicate regulatory submissions.
read more
Use of MPN for resolution of anomalous results assumes a log-linear death curve, which has never been established in a bi-phasic system.
read more
Lypophilization helps stabilize fragile new modalities, including messenger RNA and the advanced formulation vehicles that deliver them.
read more
Many patients abandon ADC therapies due to the associated toxicities. The next major leap requires designing targeted small molecules for conjugation.
read more
On 1 April this year, the Ph. Eur. Chapter 2.6.7, in its thoroughly revised form, came into force. It applies to medicinal products derived from or manufactured using living cells or biological ...
read more
In vitro anti-tubercular activity of the two novel 1,2,4-triazole derivatives demonstrated dose-dependent inhibition of Mycobacterium tuberculosis.
read more